Neuraxpharm and Panaxia Partner For Poland, After Germany And France
Companies Expect Sale Of Medical Cannabis-Based Product To Commence in First Half Of 2022
• By Akriti Seth
Panaxia Labs noted that approximately 300,000 potential patients may be eligible for medical cannabis treatments in Poland • Source: Alamy 
